News from rigel pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 24, 2009, 06:00 ET

Rigel Announces Fourth Quarter and Year End 2008 Financial Results

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter and year ended December 31, 2008. For...

Feb 05, 2009, 07:30 ET

Rigel to Present at BIO CEO & Investor Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled...

Feb 03, 2009, 06:00 ET

Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will delay further partnership discussions regarding R788 until after results...

Feb 02, 2009, 18:00 ET

Rigel to Host Conference Call on February 3, 2009

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the Company will host a conference call with simultaneous webcast on Tuesday,...

Aug 27, 2008, 01:00 ET

Rigel to Present at Thomas Weisel Partners Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower,...

Aug 05, 2008, 01:00 ET

Rigel Announces Second Quarter 2008 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for...

Jul 03, 2008, 01:00 ET

Rigel to Present at Collins Stewart Growth Conference

SAN FRANCISCO, July 3 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, Rigel's...

Jun 18, 2008, 01:00 ET

Rigel to Present at Jefferies Healthcare Conference

SOUTH SAN FRANCISCO, Calif., June 18 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower,...

Jun 12, 2008, 01:00 ET

Rigel Initiates Two Phase 2b Clinical Trials of R788 in Rheumatoid Arthritis

SOUTH SAN FRANCISCO, Calif., June 12 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the initiation of two...

Jun 05, 2008, 01:00 ET

Rigel to Present at the Needham Biotechnology and Medical Technology Conference

SOUTH SAN FRANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower,...

Jun 03, 2008, 01:00 ET

Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL

SOUTH SAN FRANCISCO, Calif., June 3 /PRNewswire-FirstCall/ -- Rigel today reported an abstract providing preliminary results of a Phase 2...

Jun 02, 2008, 01:00 ET

Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma

SOUTH SAN FRANCISCO, Calif., June 2 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will host a...

May 06, 2008, 01:00 ET

Rigel Announces First Quarter 2008 Financial Results

SOUTH SAN FRANCISCO, Calif., May 6 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the...

Apr 29, 2008, 01:00 ET

Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies

SOUTH SAN FRANCISCO, Calif., April 29 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced today that its lead product...

Apr 08, 2008, 01:00 ET

Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model

SOUTH SAN FRANCISCO, Calif., April 8, 2008 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that its oral...

Mar 27, 2008, 01:00 ET

Rigel to Present at 8th Annual Fortis Bank Biotechnology Conference

SOUTH SAN FRANCISCO, Calif., March 27 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul R....

Mar 13, 2008, 01:00 ET

Rigel Announces Participation in Upcoming Investor and Partnering Conferences

SOUTH SAN FRANCISCO, Calif., March 13 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower,...

Feb 26, 2008, 00:00 ET

Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research

SOUTH SAN FRANCISCO, Calif., Feb. 26 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has named...

Feb 12, 2008, 00:00 ET

Rigel Announces Fourth Quarter and Year End 2007 Financial Results

SOUTH SAN FRANCISCO, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced financial results for...

Feb 06, 2008, 00:00 ET

Rigel to Present at BIO CEO & Investor Conference

SOUTH SAN FRANCISCO, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower,...